Press release content from NewMediaWire. The AP news staff was not involved in its creation.
GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent
GeoVax, Inc.April 1, 2021 GMT
Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide
Atlanta, GA - ( NewMediaWire ) - April 01, 2021 - GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 16/305,305 entitled “Composition and Methods of Generating an Immune Response to Hepatitis B Virus.”